Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C and IDL by using middle dose Rosuvastatin in Saitama.

Trial Profile

Trial against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C and IDL by using middle dose Rosuvastatin in Saitama.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms PIONEER-Saitama
  • Most Recent Events

    • 27 Sep 2017 Planned number of patients changed from 90 to 200.
    • 23 Jan 2014 Status changed to completed as per University Hospital Medical Information Network - Japan.
    • 18 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top